Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Consolidated Net Income (2025 - 2026)

Updated

Drugs Made In America Acquisition's Consolidated Net Income came in at $1.73 million for Q2 2026, down 24.5% from $2.29 million a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Consolidated Net Income (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Drugs Made In America Acquisition reported Consolidated Net Income of $6.41 million; for FY2025, it came in at $5.94 million.

  • Going back by year, Consolidated Net Income was -$279,845 in FY2024.
  • The five-year range for quarterly Consolidated Net Income is $212,958 (Q4 2025) to $2.29 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 2.04 Bn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -19.38 Bn
3 Blackstone 84.08 Bn 79.01 Bn - 2.36 Bn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 703.00 Mn
5 Kkr 81.05 Bn 47.53 Bn - 1.13 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 1.17 Bn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 2.09 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 543.24 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 213.20 Mn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.73 Mn
Dec 31, 2025 212,958.00
Sep 30, 2025 2.18 Mn
Jun 30, 2025 2.29 Mn
Mar 31, 2025 1.25 Mn
API Access

Drugs Made In America Acquisition Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=DMAA&period=max&api_key=YOUR_API_KEY